Such studies typically involve the transfer of fecal microbiota from individuals exhibiting a lean phenotype to those suffering from obesity or metabolic syndrome, followed by an assessment of the impact on insulin responsiveness [59]. The gene discussed is INS; the disease is metabolic syndrome.